• Introduced
    Feb 27, 2026
  • Passed House
    Apr 13, 2026
  • Passed Senate
    May 19, 2026
  • Became Law
HB 870
Louisiana House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
Last Action See all actions
House • Jun 02, 2026: Sent to the Governor for executive approval.

Summary

Comments on HB 870

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Jun 02, 2026 | House
    • Sent to the Governor for executive approval.
  • Jun 01, 2026 | Senate
    • Signed by the President of the Senate.
  • Jun 01, 2026 | House
    • Enrolled and signed by the Speaker of the House.
  • May 31, 2026 | House
    • Notice of Senate adoption of Conference Committee Report.
  • May 31, 2026 | Senate
    • Notice House adopted the Conference Committee Report.
    • Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays.
  • May 31, 2026 | House
    • Conference Committee Report read, roll called, yeas 94, nays 0. The Conference Committee Report was adopted.
  • May 29, 2026 | House
    • Scheduled for floor debate on 05/312026.
  • May 29, 2026 | Senate
    • Conference committee report received.
  • May 29, 2026 | House
    • Conference Committee report received. Lies over under the rules.
  • May 27, 2026 | Senate
    • Notice House Conference Committee members appointed.
  • May 27, 2026 | House
    • House conferees appointed: Turner, Firment, and Miller.
  • May 26, 2026 | House
    • Notice of Senate conferees appointed.
  • May 26, 2026 | Senate
    • Notice House rejected the Senate amendments.
    • Senate conference committee members appointed: Talbot, Bass, and Harris.
  • May 26, 2026 | House
    • Read by title, roll called, yeas 99, nays 0, Senate amendments rejected, conference committee appointment pending.
  • May 25, 2026 | House
    • Scheduled for concurrence on 05/26/2026.
  • May 20, 2026 | House
    • Received from the Senate with amendments.
  • May 19, 2026 | Senate
    • Rules suspended. Called from the Calendar.
    • Senate floor amendments read and adopted. Read by title, passed by a vote of 33 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
  • May 18, 2026 | Senate
    • Rules suspended.
    • Read by title and returned to the Calendar, subject to call.
  • May 11, 2026 | Senate
    • Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
  • May 07, 2026 | Senate
    • Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
  • May 06, 2026 | Senate
    • Reported with amendments.
  • Apr 15, 2026 | Senate
    • Read second time by title and referred to the Committee on Insurance.
  • Apr 14, 2026 | Senate
    • Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
  • Apr 13, 2026 | House
    • Called from the calendar.
    • Read third time by title, amended, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.
  • Apr 09, 2026 | House
    • Read by title, returned to the calendar.
    • Notice given.
    • Scheduled for floor debate on 04/13/2026.
  • Apr 08, 2026 | House
    • Scheduled for floor debate on 04/09/2026.
  • Apr 07, 2026 | House
    • Read by title, amended, ordered engrossed, passed to 3rd reading.
  • Apr 01, 2026 | House
    • Reported with amendments (10-0).
  • Mar 09, 2026 | House
    • Read by title, under the rules, referred to the Committee on Insurance.
  • Feb 27, 2026 | House
    • Prefiled.
    • Under the rules, provisionally referred to the Committee on Insurance.
    • First appeared in the Interim Calendar on 2/27/2026.